Latest filing published 09 Mar 2012 for Iovance Biotherapeutics, INC., €696.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Martin Schroeder: trading record in brief
Martin Schroeder discloses dealings in Iovance Biotherapeutics, Inc. to SEC (Form 4). In total, 2 filings cover trades dated 22 August 2011.
Purchases make up the whole of the open-market record (1 purchase, €696). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. So far in 2012, the count stands at 1 purchase and no sales.
On 9 March 2012 came the latest disclosure, an open-market purchase for €696 in Iovance Biotherapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Martin Schroeder
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ US$0.001Common StockSEC:0001181431-12-016128:0Canonical exit: 20 Nov 2011 (T+90)
- 1,000,000 shares@ US$1.13Common StockSEC:0001513160-11-000062:0
2 of 2 declarations
